Copyright
©The Author(s) 2018.
World J Hepatol. Nov 27, 2018; 10(11): 799-806
Published online Nov 27, 2018. doi: 10.4254/wjh.v10.i11.799
Published online Nov 27, 2018. doi: 10.4254/wjh.v10.i11.799
Table 2 The most frequently prescribed herbal medicines used in the treatment of patients with hepatocellular carcinoma
| Herb name | Relative frequency | Herb name | Relative frequency |
| Poria (Fuling) | 5.20% | Radix Angelicae Sinensis (Danggui) | 2.35% |
| Rhizoma Atractylodis Macrocephalae (Baizhu) | 5.20% | Carapax Trionycis (Biejia) | 2.22% |
| Radix Astragali Mongolici (Huangqi) | 4.07% | Radix Bupleuri Chinensis (Chaihu) | 3.66% |
| Herba Hedyotidis (Baihuasheshecao) | 3.75% | Radix Codonopsis (Dangshen) | 3.26% |
| Radix Glycyrrhizae (Gancao) | 3.71% | Radix Paeoniae Alba (Baishao) | 3.03% |
- Citation: Xi SY, Minuk GY. Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma. World J Hepatol 2018; 10(11): 799-806
- URL: https://www.wjgnet.com/1948-5182/full/v10/i11/799.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i11.799